Top Markets
#1 TENDIES TENDIES +36.52%
#2 Cash Cat Cash Cat +27.12%
#3 Asteroid Shiba Asteroid Shiba +16.52%
#4 MarsCoin MarsCoin +15.71%
#5 OSK OSK +15.36%
#6 龙虾 (Lobster) 龙虾 (Lobster) +10.48%
#7 Tornado Cash Tornado Cash +9.52%
#8 Threshold Network Threshold Network +9.46%
#9 Kite Kite +7.57%
#10 Ardor Ardor +6.84%
Coin of the day
TENDIES TENDIES
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
NervGen Pharma Corp. NervGen Pharma Corp.

NervGen Pharma Corp.

NGEN
Rang in Aktien #16730
NervGen Pharma Corp., along with its affiliated entities, is a pharmaceutical... NervGen Pharma Corp., along with its affiliated entities, is a pharmaceutical company dedicated to discovering, advancing, and commercializing innovative drug therapies for neurological conditions involving nerve damage. Its flagship investigational therapy, NVG-291, is currently undergoing Phase 1 clinical trials, targeting significant neurological disorders such as spinal cord injuries (SCI), multiple sclerosis, and Alzheimer's disease. NervGen has also secured an exclusive licensing agreement with Case Western Reserve University. This partnership enables the company to research, advance, and commercialize a proprietary technology holding considerable therapeutic promise for SCI and a range of other nerve-related ailments. Established in 2017, NervGen Pharma Corp. maintains its headquarters in Vancouver, Canada.
Aktienkurs
$3.78
Zuletzt synchronisiert: 2026-03-17
Marktkapitalisierung
$276.54M
Veränderung (1 Tag)
0.00%
Veränderung (1 Jahr)
45.53%
Land
CA
Handel NervGen Pharma Corp. (NGEN)

Kategorie

Healthcare
EPS für NervGen Pharma Corp. (NGEN)
EPS zum 2026 TTM: 0
Laut den aktuellen Finanzberichten und dem Aktienkurs von NervGen Pharma Corp. beträgt das aktuelle EPS des Unternehmens (TTM) 0. Am Ende des Jahres 2026 betrug das EPS 0 gleich wie dem EPS von 2026, das 0 betrug.
EPS-Verlauf von NervGen Pharma Corp. von 2026 bis 2026
EPS am Ende jedes Jahres
Jahr EPS ändert
Nicht genügend Daten für die angegebenen Daten.
EPS für ähnliche Unternehmen oder Wettbewerber
Unternehmen EPS EPS-Differenz Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $17.32 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $27.74 -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $-7.98 -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $-5.29 -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH